Sort
82,697 grants matching “vaccine development”
Modernization of high and maximum containment research facilities at the National Emerging Infectious Diseases Laboratories (NEIDL) to meet current and future national research priorities
$7,541,758Nancy Jean Sullivan · Boston University Medical Campus · C06 · FY2024 · OD
The Southwest National Primate Research Center
$7,520,767Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2011 · RR
Clinical and Translational Science Center
$7,516,933Julianne L Imperato-McGinley · Weill Medical Coll Of Cornell Univ · UL1 · FY2024 · TR
EO-NAT HIV Rapid Point-of-Care Diagnostic Device for Resource-Limited Settings
$7,514,711Wave 80 Biosciences, Inc. · N01 · FY2009 · AI
Project 1: Adjuvanted Protein Vaccines for Pandemic Preparedness
$7,511,446Li Liang · University Of California-Irvine · U19 · FY2024 · AI
Kaiser Washington VTEU supplement 20-0003
$7,505,188Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2020 · AI
GH21-003, Advancing Public Health Research in Kenya
$7,500,000M Kariuki Njenga · Washington State University · U01 · FY2023 · GH
Nanoemulsions as novel adjuvants for intranasal vaccines
$7,496,543James Baker · University Of Michigan At Ann Arbor · N01 · FY2009 · AI
Dengue Human Immunology Project Consortium (DHIPC)
$7,495,258Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Institute for Clinical and Translational Research
$7,485,218Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2013 · TR
Enhancing the Safety, Efficiency, and Research Capacity of the University of Pittsburgh Regional Biocontainment Laboratory to Study Virus Families of Greatest Pandemic Concern
$7,480,973Anantha Shekhar · University Of Pittsburgh At Pittsburgh · G20 · FY2022 · AI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou
$7,473,569John T Belisle · Colorado State University · U54 · FY2009 · AI
Operations and Management support component
$7,471,727Barton F Haynes · Duke University · UM1 · FY2012 · AI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
$7,456,617Barbara Driver · Westat, Inc. · UM2 · FY2023 · HD
GMP Production of Envelope Immunogens
$7,455,307Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2019 · AI
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$7,452,280Margaret Rita Karagas · Dartmouth College · UG3 · FY2024 · OD
IGF::OT::IGF DUAL AFFINITY RE-TARGETING MOLECULES FOR HIV-1 SUPPRESSION
$7,449,454Jeffrey Nordstrom · Macrogenics, Inc. · N01 · FY2015 · AI
Clinical Studies of Vaccines for Pandemic Influenza
$7,446,758Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
The Southwest National Primate Research Center
$7,441,831Robert W Gracy · Texas Biomedical Research Institute · P51 · FY2014 · OD
Consortium for AIDS Vaccine Research in Nonhuman Primates
$7,440,564Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Treatment of Peanut Allergy with Intradermal Administration of ASP0892 (ARA-LAMP-vax): A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study
$7,439,953Robert A Wood · Johns Hopkins University · UM2 · FY2023 · AI
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
$7,435,152Elizabeth Renata Brown · Fred Hutchinson Cancer Research Center · UM1 · FY2011 · AI
The Southwest National Primate Research Center
$7,431,656Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2010 · RR
GH21-003, Advancing Public Health Research in Kenya
$7,426,960M Kariuki Njenga · Washington State University · U01 · FY2022 · GH
System Biological Analyses of Innate and Adaptive Responses to Vaccination
$7,425,306Bali Pulendran · Emory University · U19 · FY2020 · AI